Appears On
Episode Appearances
Bloomberg Intelligence · Jul 16, 2026
Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker
“Covered TSMC earnings, semiconductor supply dynamics, AI chip demand, and US manufacturing expansion”
Psychedelic Drug Development and RegulationEli Lilly M&A Strategy and Contingent Value RightsPCSK9 Inhibitors and Cholesterol Management
View Analysis